Henning Hafermann

Amyloid-β-Secondary Structure Distribution in Cerebrospinal Fluid and Blood Measured by an Immuno-Infrared-Sensor: A Biomarker Candidate for Alzheimer’s Disease

Andreas Nabers, Julian Ollesch, Jonas Schartner et al. · Analytical Chemistry · 2016 · 112 citations

Life Sciences, Neurology, Neuroscience +17

Aβ and tau structure‐based biomarkers for a blood‐ and CSF‐based two‐step recruitment strategy to identify patients with dementia due to Alzheimer's disease

Andreas Nabers, Henning Hafermann, Jens Wiltfang et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2019 · 49 citations · Full text

Life Sciences, Neuroscience, Biosensors +16

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany

Norbert Scherbaum, Udo Bonnet, Henning Hafermann et al. · Frontiers in Psychiatry · 2021 · 36 citations · Full text

Nursing, Psychiatry, Addiction Psychiatry +12

Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort

Hans-W. Klafki, Henning Hafermann, Chris Bauer et al. · Journal of Alzheimer s Disease · 2016 · 19 citations · Full text

Life Sciences, Neurology, Neuroscience +16